Legislative Activity

The Adams Memorial-Great American Heroes Act extends the authority of the Adams Memorial Commission until 2032 and approves a specific location for the memorial, allowing it to proceed despite certain location standards. The bill also grants the Commission flexibility to relocate the memorial to the "Reserve" if the primary site proves unsuitable. Finally, it makes technical amendments to existing law to align dates and clarify the memorial's authorization.

The HELP Copays Act requires that financial assistance provided by non-profit organizations and drug manufacturers must count toward a patient's deductible, copayments, and out-of-pocket maximums for prescription drugs. This change ensures that patient assistance dollars directly reduce the amount a patient must pay before their coverage fully kicks in. The legislation specifically applies to specialty drugs and those subject to utilization management. These provisions will take effect for plan years beginning on or after January 1, 2026.

This resolution strongly condemns the Iranian government for its ongoing, state-sponsored persecution of the Baha'i religious minority, which violates international human rights laws. It documents systematic abuses, including economic restrictions, denial of education, and arbitrary arrests, noting that these actions may constitute a crime against humanity. The resolution calls on Iran to immediately release all imprisoned Bahais and urges the U.S. President and Secretary of State to condemn these violations and impose sanctions on responsible officials.

The Mikaela Naylon Give Kids a Chance Act focuses primarily on improving pediatric drug development and ensuring patient access to necessary treatments. This legislation mandates new research requirements for molecularly targeted pediatric cancer drugs, strengthens FDA enforcement of pediatric study completion, and extends incentives for developing drugs for rare pediatric diseases. Additionally, the bill updates organ transplant network functions and establishes an Abraham Accords Office within the FDA to enhance international regulatory cooperation.

The AIM Act primarily focuses on eliminating numerous existing statutory restrictions and prohibitions that currently limit the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) in its operations. This includes removing limitations on the use and analysis of firearms trace data and allowing for the consolidation of dealer records. Furthermore, the bill removes requirements for the destruction of background check records and eases restrictions on the ATF's ability to inspect dealer inventories and deny or revoke Federal Firearms Licenses.

The Health ACCESS Act amends federal law to create an exception to prohibitions against offering remuneration to influence healthcare decisions. This change specifically allows providers to pay information service platforms for participation, provided the platform adheres to strict guidelines ensuring unbiased consumer choice. These guidelines prohibit steering patients, targeted marketing, and sharing consumer contact information outside of a confirmed selection. Ultimately, this bill aims to facilitate easier consumer access to healthcare providers through regulated self-scheduling platforms.

The Bivens Act of 2025 amends existing law to redefine the scope of civil actions that can be brought against individuals acting under federal authority. This legislation specifically revises Section 1979 of the Revised Statutes concerning such lawsuits. The core change narrows the focus of these civil actions to exclusively target persons acting under the authority of the United States.

The Biomanufacturing Excellence Act of 2025 aims to bolster U.S. leadership in biotechnology by establishing a National Biopharmaceutical Center of Excellence. This Center will accelerate manufacturing innovation, strengthen domestic supply chains, and ensure adherence to quality standards. It will also facilitate crucial workforce training to support the growing biomanufacturing sector.

The Restoring Food Security for American Families and Farmers Act of 2025 aims to strengthen domestic food security by repealing specific sections of a prior reconciliation act. This action effectively revives the original laws that were previously amended by the repealed provisions. The bill seeks to revert existing agricultural and food-related statutes to their pre-amendment status.

The Stop Excessive Force in Immigration Act of 2025 establishes strict new standards for the use of non-deadly force by federal immigration personnel, requiring proportionality and de-escalation efforts. The bill mandates identification requirements, restricts the use of certain crowd-control equipment, and imposes new body camera and detailed reporting mandates. Furthermore, it creates affirmative duties for officers to intervene against excessive force and requires annual training on these new policies.

This resolution expresses strong support for Gavi, the Vaccine Alliance, recognizing its critical role in saving children's lives through global immunization efforts in low-income countries. It highlights Gavi's proven success in delivering vaccines, strengthening health systems, and providing a significant return on investment. The bill encourages the U.S. to maintain and increase its financial commitment to Gavi to ensure global health security and future vaccine access.

The REPO for Ukrainians Implementation Act of 2025 formally recognizes international calls to repurpose frozen Russian sovereign assets to aid Ukraine. This bill grants the President authority to transfer non-confiscated Russian assets into the Ukraine Support Fund, where they must be invested in U.S. government debt. Furthermore, the Secretary of State is mandated to obligate at least $250 million from the fund to Ukraine every quarter. The Act also requires the President to report on the location of these Russian assets globally and directs diplomatic efforts to encourage allies to contribute quarterly.

The Penicillin Allergy Verification and Evaluation (PAVE) Act addresses the widespread issue of inaccurate penicillin allergy labels, which often lead to poorer patient outcomes. This bill mandates that Medicare cover and require physicians to perform a formal penicillin allergy verification and evaluation for seniors during their initial and annual wellness visits. The goal is to correctly identify patients who can safely take penicillin, improving care and promoting responsible antibiotic stewardship.

This resolution strongly condemns the brutal October 7th attacks by Hamas, demanding the immediate and unconditional surrender of the terrorist group and the release of all hostages, including Americans. It reaffirms Israel's right to self-defense while urging international action against Hamas and condemning the global surge in antisemitism. The measure serves as a formal statement of U.S. policy and support following the attacks.

This bill ensures that states are reimbursed by the Federal Government for any state funds they use to maintain essential operations of the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) during a lapse in federal appropriations. It provides a mechanism for the Federal Government to pay back states that cover WIC costs during a government shutdown. This protects state budgets while keeping vital nutrition assistance running.

The Medical Foods and Formulas Access Act of 2025 mandates federal health programs, including Medicare and Medicaid, to cover medically necessary specialized foods and formulas prescribed for managing severe digestive or inherited metabolic disorders. This ensures patients with conditions like urea cycle disorders or short bowel syndrome receive essential, prescribed nutrition when standard food is insufficient. The bill aims to standardize access to these life-sustaining treatments across federal and state health plans.

The Fair Pay for Federal Contractors Act of 2025 ensures that employees of federal contractors are compensated for losses incurred due to government funding lapses or shutdowns. It requires federal agencies to adjust existing contracts to cover reasonable costs associated with furloughs, pay cuts, or mandatory leave taken by contractor employees. The bill appropriates necessary funds to cover these contract price adjustments and mandates public reporting on the compensation provided.

The Baltic Security Assessment Act of 2025 affirms the critical importance of Estonia, Latvia, and Lithuania to U.S. national security amidst Russian aggression. This bill mandates that the Secretary of State and Secretary of Defense deliver a comprehensive report to Congress detailing emerging military, cyber, and political threats to the Baltic states. The report must also recommend specific actions to enhance U.S. and NATO defense cooperation and bolster Baltic resilience.

The Biosimilar Red Tape Elimination Act streamlines the regulatory pathway for biosimilar biological products by making technical and structural updates to existing law. This legislation clarifies when a biosimilar is automatically deemed "interchangeable" with its reference product, protecting existing exclusivity periods. Furthermore, it updates conforming language across federal drug laws and clarifies pediatric testing requirements for biosimilar applications.

This House Resolution strongly condemns all forms of political violence and threats against elected officials and public figures, regardless of political affiliation. It affirms that disagreements must be resolved through peaceful and democratic means, not intimidation or force. The resolution urges law enforcement to prosecute those who commit or encourage such violence. Finally, it calls on all leaders to cease using dehumanizing rhetoric and promote civil discourse.